Suvorexant | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Suvorexant
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Suvorexant

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 4 USDMF, 2 NDC API, 11 Listed Suppliers, $ API Reference Price

14 API Suppliers
4 USDMF
2 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 4 FDA Orange Book

4 FDF Dossiers
4 FDA Orange Book

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 37 Fillers, Diluents & Binders, 18 Direct Compression, 17 Granulation, 15 Controlled & Modified Release, 14 Disintegrants & Superdisintegrants, 11 Thickeners and Stabilizers, 10 Film Formers & Plasticizers, 9 Lubricants & Glidants, 8 Co-Processed Excipients, 5 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Solubilizers, 2 Emulsifying Agents, 1 Parenteral

40 Coating Systems & Additives
37 Fillers, Diluents & Binders
18 Direct Compression
17 Granulation
15 Controlled & Modified Release
14 Disintegrants & Superdisintegrants
11 Thickeners and Stabilizers
10 Film Formers & Plasticizers
9 Lubricants & Glidants
8 Co-Processed Excipients
5 Taste Masking
5 Empty Capsules
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Solubilizers
2 Emulsifying Agents
1 Parenteral

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

1 Data Compilation #PharmaFlow
16 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Annual Reports

1 US Medicaid Prescriptions
6 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

12 US Patents, 7 Health Canada Patents

12 US Patents
7 Health Canada Patents

$ API Ref.Price (USD/KG) : 22,415 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Merck Canada Inc.

filter Patent Reset all filters

7 All

01 42670892

02 32795550

filter Product Reset all filters

7 All

01 7SUVOREXANT

filter Dosage Reset all filters

7 All

01 7TABLET

filter Exp Date Reset all filters

7 All

01 42027-11-30

02 32032-11-13

Product Main Page

01

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Brand Name : BELSOMRA

Patent Number : 2670892

Filing Date : 2007-11-30

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Brand Name : BELSOMRA

Patent Number : 2670892

Filing Date : 2007-11-30

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Brand Name : BELSOMRA

Patent Number : 2670892

Filing Date : 2007-11-30

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Brand Name : BELSOMRA

Patent Number : 2670892

Filing Date : 2007-11-30

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-11-30

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Brand Name : BELSOMRA

Patent Number : 2795550

Filing Date : 2012-11-13

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Brand Name : BELSOMRA

Patent Number : 2795550

Filing Date : 2012-11-13

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Merck Canada Inc.

Suvorexant

Peptide Process CMC

Not Confirmed

Merck Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Brand Name : BELSOMRA

Patent Number : 2795550

Filing Date : 2012-11-13

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-13

Date Granted : 2020-03-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!